This session addresses new medications for the treatment of dementia in older adults, including the common pharmacological classes of medications used, mechanisms of action and potential side effects, and expectations of patients and caregivers related to use.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 3/23/2026.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.

Speakers Disclosures:
There are no speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5387.

Learning Outcome:
After completing this learning activity, participants will be able to list the common pharmacological classes of medications used in the management of dementia and describe their mechanisms of action.

Dawn Gerber PharmD, BCGP, FASCP, FAzPA

Appearances